Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study. [electronic resource]
Producer: 20050719Description: 934-9 p. digitalISSN:- 0022-3050
- Aged
- Aged, 80 and over
- Cholinesterase Inhibitors -- adverse effects
- Cross-Over Studies
- Dementia -- diagnosis
- Donepezil
- Double-Blind Method
- Female
- Humans
- Indans -- adverse effects
- Male
- Middle Aged
- Neuropsychological Tests
- Parkinson Disease -- diagnosis
- Piperidines -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.